| Title |
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
|
|---|---|
| Published in |
JAMA Oncology, December 2019
|
| DOI | 10.1001/jamaoncol.2019.3323 |
| Pubmed ID | |
| Authors |
Li Sun, Adam Brentnall, Shreeya Patel, Diana S. M. Buist, Erin J. A. Bowles, D. Gareth R. Evans, Diana Eccles, John Hopper, Shuai Li, Melissa Southey, Stephen Duffy, Jack Cuzick, Isabel dos Santos Silva, Alec Miners, Zia Sadique, Li Yang, Rosa Legood, Ranjit Manchanda |
X Demographics
The data shown below were collected from the profiles of 228 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 58 | 25% |
| United Kingdom | 17 | 7% |
| Japan | 9 | 4% |
| Mexico | 8 | 4% |
| Spain | 8 | 4% |
| Canada | 6 | 3% |
| Belgium | 5 | 2% |
| France | 4 | 2% |
| Ireland | 3 | 1% |
| Other | 27 | 12% |
| Unknown | 83 | 36% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 139 | 61% |
| Scientists | 47 | 21% |
| Practitioners (doctors, other healthcare professionals) | 39 | 17% |
| Science communicators (journalists, bloggers, editors) | 3 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 195 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 195 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 30 | 15% |
| Student > Ph. D. Student | 19 | 10% |
| Student > Master | 18 | 9% |
| Other | 14 | 7% |
| Student > Postgraduate | 14 | 7% |
| Other | 32 | 16% |
| Unknown | 68 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 43 | 22% |
| Biochemistry, Genetics and Molecular Biology | 17 | 9% |
| Agricultural and Biological Sciences | 10 | 5% |
| Nursing and Health Professions | 8 | 4% |
| Social Sciences | 7 | 4% |
| Other | 32 | 16% |
| Unknown | 78 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 263. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2022.
All research outputs
#141,523
of 25,793,330 outputs
Outputs from JAMA Oncology
#248
of 3,367 outputs
Outputs of similar age
#3,111
of 481,428 outputs
Outputs of similar age from JAMA Oncology
#6
of 88 outputs
Altmetric has tracked 25,793,330 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,367 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 84.0. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 481,428 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 88 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.